Table 2. Baseline characteristics of biomarkers in 239 patients with SARS-CoV-2.
Total (n=239) | Age<60 (n=181) | Age≥60 (n=58) | p-value | |
White blood cells (×109 cells/L) | 4.58(3.48-5.69) | 4.59(3.47-5.73) | 4.55(3.63-5.41) | 0.523 |
Lymphocytes (×109 cells/L) | 1.14(0.85-1.60) | 1.25(0.90-1.70) | 0.98(0.64-1.19) | <0.001 |
Neutrophils (×109 cells/L) | 2.89(2.12-3.64) | 2.86(2.03-3.61) | 3.02(2.39-3.66) | 0.261 |
Eosinophils (×109 cells/L) | 0.01(0-0.04) | 0.01(0-0.05) | 0.01(0-0.03) | 0.010 |
Hemoglobin (g/L) | 130(120-141) | 132(122-143) | 123(115.50-134.75) | 0.001 |
Platelets (×109/L) | 171(138-227) | 179(146-228) | 147.50(117.25-206.50) | 0.005 |
D-dimer (mg/L) | 0.27(0.14-0.54) | 0.22(0.13-0.48) | 0.38(0.17-0.71) | 0.013 |
C-reactive protein (mg/L) | 15.60(4.36-30.85) | 12.10(3.55-24.07) | 30.11(15.80-55.19) | <0.001 |
Alanine aminotransferase (U/L) | 19.45(14.21-27.48) | 19.69(14.20-27.79) | 18.22(14.22-26.36) | 0.486 |
Aspartate aminotransferase (U/L) | 24.40(19.80-31.37) | 23.38(18.85-28.75) | 27.90(23.46-35.87) | <0.001 |
Total bilirubin (μmol/L) | 10.87(8.19-15.80) | 10.92(8.02-15.60) | 10.80(9.02-16.07) | 0.665 |
Albumin (g/L) | 38.23(35.36-40.97) | 38.98(36.21-41.75) | 35.56(32.17-38.32) | <0.001 |
Albumin/globulin | 1.50(1.31-1.72) | 1.53(1.39-1.78) | 1.33(1.23-1.48) | <0.001 |
Blood urea nitrogen(mmol/L) | 4.22(3.19-5.11) | 4.12(3.14-4.88) | 4.70(3.88-6.45) | 0.003 |
Creatinine (μmol/L) | 50.21(39.99-63.34) | 49.85(39.8-62.19) | 52.44(43.41-64.90) | 0.227 |
Lactic acid | 768.35(392.65-824.70) | 761.40(391.60-808.10) | 773.40(742.50-837.30) | 0.482 |